Annual report pursuant to Section 13 and 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Income Statement [Abstract]    
Revenues $ 933 $ 203,640
Cost of sales 280
Gross profit 653 203,640
Operating expenses:    
Research and development 993,934 860,533
Occupancy 83,808 57,530
Depreciation & amortization 12,607 12,298
Officer compensation 650,731 237,209
Professional fees 905,469 440,007
Other operating expenses 42,275 48,371
Total operating expenses 2,688,824 1,655,948
Loss from operations (2,688,171) (1,452,308)
Other income (expense):    
Gain on sale of assets 180,248
Change in fair value of derivative liabilities 4,193,081 (2,094,319)
Interest income 2 3
Interest expense (376,085) (10,399)
Total other income (expense) 3,816,998 (1,924,467)
Income (loss) before income taxes 1,128,827 (3,376,775)
Income tax expense
Net income (loss) 1,128,827 (3,376,775)
Accretion on Series A preferred stock   (1,500,004)
Net income (loss) attributed to common shareholders $ 1,128,827 $ (4,876,779)
Basic net income (loss) per common share $ 0.02 $ (0.12)
Diluted net income (loss) per common share $ 0.02 $ (0.12)
Basic weighted average common shares outstanding 46,421,363 41,981,212
Diluted weighted average common shares outstanding 69,720,326 41,981,212